Guangdong Biolight Hits Day Low of CNY 12.53 Amid Price Pressure

Guangdong Biolight Meditech Co., Ltd. experienced a significant decline today, with the stock dropping by 7.39% on March 23, 2026. The stock reached an intraday low of CNY 12.53, reflecting a challenging trading environment. Over the past week, the stock has seen a notable decrease of 16.6%, contrasting with the China Shanghai Composite's decline of 6.65% during the same period. In terms of longer-term performance, Guangdong Biolight has shown a year-to-date increase of 56.3%, significantly outperforming the China Shanghai Composite, which has fallen by 3.92%. However, the stock's three-year performance remains negative at -17.04%, and its five-year performance has declined by 46.96%. Financial metrics indicate that the company has faced difficulties, with net sales declining at an annual rate of 4.48% and operating profit decreasing by 173.40% over the last five years. The company's market capitalization stands at CNY 2,751 million, categorizing it as a small-cap entity in the pharmaceuticals and biotechnology sector.